SC4MOL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.017200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.669600E-01
Normal-vs-Stage2
5.697200E-01
Normal-vs-Stage3
9.413200E-01
Normal-vs-Stage4
4.185600E-01
Stage1-vs-Stage2
9.779600E-01
Stage1-vs-Stage3
6.931800E-01
Stage1-vs-Stage4
7.868200E-01
Stage2-vs-Stage3
5.767800E-01
Stage2-vs-Stage4
6.744800E-01
Stage3-vs-Stage4
4.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.187800E-01
Normal-vs-AfricanAmerican
7.733400E-01
Normal-vs-Asian
5.255000E-01
Caucasian-vs-AfricanAmerican
6.522800E-01
Caucasian-vs-Asian
5.661200E-01
AfricanAmerican-vs-Asian
3.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.928000E-01
Normal-vs-Female
6.289600E-01
Male-vs-Female
6.273800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.500800E-01
Normal-vs-Age(41-60Yrs)
6.006800E-01
Normal-vs-Age(61-80Yrs)
6.026400E-01
Normal-vs-Age(81-100Yrs)
4.998600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.374000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.690400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.178820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.373600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.644600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.269800E-01
Normal-vs-Daily Drinker
7.423200E-01
Normal-vs-Weekly Drinker
8.304200E-01
Normal-vs-Occasional Drinker
5.691000E-01
Normal-vs-Social Drinker
6.104200E-01
Non Drinker-vs-Daily Drinker
2.418600E-01
Non Drinker-vs-Weekly Drinker
2.017600E-01
Non Drinker-vs-Occasional Drinker
4.019000E-01
Non Drinker-vs-Social Drinker
4.272800E-01
Daily Drinker-vs-Weekly Drinker
8.284000E-01
Daily Drinker-vs-Occasional Drinker
6.757400E-01
Daily Drinker-vs-Social Drinker
7.111000E-01
Weekly Drinker-vs-Occasional Drinker
5.472600E-01
Weekly Drinker-vs-Social Drinker
5.906000E-01
Occasional Drinker-vs-Social Drinker
9.913200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.888300E-02
Normal-vs-Grade 2
1.089160E-01
Normal-vs-Grade 3
1.105940E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.935300E-03
Grade 1-vs-Grade 3
2.275200E-01
Grade 1-vs-Grade 4
9.888300E-02
Grade 2-vs-Grade 3
1.295660E-02
Grade 2-vs-Grade 4
1.089160E-01
Grade 3-vs-Grade 4
1.105940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.241200E-01
Normal-vs-NonDiabetic
5.374200E-01
Diabetic-vs-NonDiabetic
4.792000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.006800E-01
Normal-vs-NoPancreatitis
6.154800E-01
Pancreatitis-vs-NoPancreatitis
2.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.866800E-01
Normal-vs-N1
6.047200E-01
N0-vs-N1
8.937400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.759000E-01
Normal-vs-TP53-NonMutant
7.111800E-01
TP53-Mutant-vs-TP53-NonMutant
1.811820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
